ECPG
Encore Capital Group, Inc.
ECPG's fundamentals are strong: revenue grew 27% and its operating margin rose 19 points to 39%. At 7.1x earnings, it's trading above its usual 6.2x. Analysts expect that strong growth to continue, though they disagree widely on how much.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ECPG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ECPG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ECPG.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ECPG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.4x | $68.62 | -38% |
| Fair | 6.2x | $96.38 | -12% |
| Forward | 6.8x | $110 | — |
| Current | 7.1x | $110 | — |
| Expensive | 11x | $164 | +49% |
Historical ranges are pointers, not guarantees.
ECPG's PE is in its expensive range at 7.1x. If earnings grow as analysts expect, today's price would be 6.8x next year's earnings, in its fair range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ECPG Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
ECPG has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ECPG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $16.12 | +3.6% |
| Q3 2026 | $15.56 | +$17.35 |
| Q2 2026 | $13.16 | +$16.86 |
| Q1 2026 | $12.84 | +$17.69 |
| Q4 2025 | $10.91 | +$16.74 |
| Q3 2025 | -$1.79 | +$6.00 |
| Q2 2025 | -$3.70 | +$4.56 |
| Q1 2025 | -$4.85 | +$3.67 |
| Q4 2024 | -$5.83 | +$2.89 |
ECPG has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ECPG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $544.5M | +18% |
| Q2 2026 | $491.9M | +11% |
| Q1 2026 | $475.4M | +21% |
| Q4 2025 | $473.6M | +78% |
| Q3 2025 | $460.4M | +25% |
| Q2 2025 | $442.1M | +24% |
| Q1 2025 | $392.8M | +20% |
| Q4 2024 | $265.6M | -4.2% |
ECPG's revenue has grown year over year for seven quarters in a row: $545M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 42% | +4.7 points |
| Q2 2026 | 38% | +3.9 points |
| Q1 2026 | 39% | +5.8 points |
| Q4 2025 | 37% | +87 points |
| Q3 2025 | 38% | +8.7 points |
| Q2 2025 | 34% | +5.4 points |
| Q1 2025 | 33% | +7.5 points |
| Q4 2024 | -51% | +28 points |
ECPG has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ECPG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $101.9M | +35% |
| Q2 2026 | -$37.8M | -1283% |
| Q1 2026 | $77.5M | +102% |
| Q4 2025 | $9.9M | -34% |
| Q3 2025 | $75.6M | +90% |
| Q2 2025 | $3.2M | -89% |
| Q1 2025 | $38.3M | -13% |
| Q4 2024 | $15M | -48% |
ECPG has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ECPG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -536K shares |
| 1 year | -5.4% | -1.3M shares |
| 3 years | -8.7% | -2.1M shares |
| 5 years | -29% | -9.2M shares |
| Available history | -29% | -9.2M shares |
ECPG has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | $25.6M |
| Q4 2022 | $10.4M |
| Q3 2022 | $25.9M |
| Q2 2022 | $25.1M |
| Q1 2022 | $25.7M |
| Q4 2021 | $302.5M |
| Q3 2021 | $40.7M |
| Q2 2021 | $27M |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ECPG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 5.9x | High |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | 18.5x | High |
ECPG has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like ECPG.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ECPG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.4 | Neutral |
| Stochastic | 58.7 | Neutral |
ECPG's weekly RSI is 68 (neutral) and its Stochastic is 59 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ECPG PE vs Financial Services Sector
| Metric | ECPG | Sector median | Relative |
|---|---|---|---|
| PE | 7.1x | 13x | 46% below |
| PE % | 67 | 63 | 4 pts above |
ECPG is trading at 7.1x earnings, a 46% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ECPG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $102.2 | 7.5% above |
| 20 week MA | $98.8 | 11% above |
| 50 week MA | $80.9 | 36% above |
| 100 week MA | $61.2 | 79% above |
| 200 week MA | $54.5 | 101% above |
ECPG has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ECPG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.0 | $37.8 | +5.1% |
| 2021 | $37.8 | $60.2 | +59% |
| 2022 | $60.2 | $47.2 | -22% |
| 2023 | $47.2 | $50.8 | +7.6% |
| 2024 | $50.8 | $47.5 | -6.4% |
| 2025 | $47.5 | $55.5 | +17% |
| 2026 YTD | $55.5 | $109.9 | +98% |
ECPG has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.